Hazel Allardyce
Overview
Explore the profile of Hazel Allardyce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allardyce H, Lawrence B, Crawford T, Sumner C, Parson S
Neuropathol Appl Neurobiol
. 2024 Oct;
50(5):e13013.
PMID: 39449271
Aims: Spinal muscular atrophy (SMA) is a life-limiting paediatric motor neuron disease characterised by lower motor neuron loss, skeletal muscle atrophy and respiratory failure, if untreated. Revolutionary treatments now extend...
2.
Allardyce H, Shepherd E, Bailey E
J Anat
. 2022 Mar;
242(1):112-120.
PMID: 35301720
The prevalence and complexity of cardiovascular disease (CVD) in the West of Scotland are high with the aortic arch and abdominal aorta, particularly at increased risk of cardiovascular pathology. Stent...
3.
Allardyce H, Kuhn D, Hernandez-Gerez E, Hensel N, Huang Y, Faller K, et al.
Hum Mol Genet
. 2020 Jun;
29(14):2365-2378.
PMID: 32588893
Spinal muscular atrophy (SMA) occurs as a result of cell-ubiquitous depletion of the essential survival motor neuron (SMN) protein. Characteristic disease pathology is driven by a particular vulnerability of the...
4.
Soltic D, Shorrock H, Allardyce H, Wilson E, Holt I, Synowsky S, et al.
Hum Mol Genet
. 2019 Aug;
28(21):3515-3527.
PMID: 31397869
Cardiac pathology is emerging as a prominent systemic feature of spinal muscular atrophy (SMA), but little is known about the underlying molecular pathways. Using quantitative proteomics analysis, we demonstrate widespread...